EXTON, Pa. (AP) — EXTON, Pa. (AP) — West Pharmaceutical Services Inc. (WST) on Thursday reported fourth-quarter profit of $132.1 million.

On a per-share basis, the Exton, Pennsylvania-based company said it had net income of $1.82. Earnings, adjusted for non-recurring costs and restructuring costs, were $2.04 per share.

The results topped Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for earnings of $1.83 per share.

The medical device company posted revenue of $805 million in the period, also exceeding Street forecasts. Six analysts surveyed by Zacks expected $794.3 million.

For the year, the company reported profit of $493.7 million, or $6.79 per share. Revenue was reported as $3.07 billion.

West Pharmaceutical expects full-year earnings in the range of $7.85 to $8.20 per share, with revenue in the range of $3.22 billion to $3.28 billion.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on WST at https://www.zacks.com/ap/WST